A clinical trial involving vasoactive intestinal peptide has been updated as of June 3, 2026. The study, registered as NCT01786304 and titled "Effect of Sacral Nerve Stimulation on Enteric Nervous System," is listed with a status of completed. The trial phase is listed as not applicable. Vasoactive intestinal peptide is an approved compound referenced in connection with this study on the enteric nervous system and sacral nerve stimulation. No results, efficacy data, or safety findings were included in this update. The current status reflects only that the trial has reached completion, not the outcome of its findings. Details on study design, endpoints, or conclusions have not been provided as part of this update. Readers seeking further information can consult the official trial registration for additional context. For general background on vasoactive intestinal peptide, its approved status, and its role in relevant research, readers can refer to the compound overview.
Trial Update: VIP-Related Study on Sacral Nerve Stimulation Completed
See the full vasoactive intestinal peptide overview
Source: https://clinicaltrials.gov/study/NCT01786304